<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="508">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02484547</url>
  </required_header>
  <id_info>
    <org_study_id>221AD302</org_study_id>
    <secondary_id>2015-000967-15</secondary_id>
    <nct_id>NCT02484547</nct_id>
  </id_info>
  <brief_title>221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease</brief_title>
  <acronym>EMERGE</acronym>
  <official_title>A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biogen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biogen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab&#xD;
      in slowing cognitive and functional impairment as measured by changes in the Clinical&#xD;
      Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with&#xD;
      early AD. Secondary objectives are to assess the effect of monthly doses of aducanumab as&#xD;
      compared with placebo on clinical progression as measured by Mini-Mental State Examination&#xD;
      (MMSE), AD Assessment Scale-Cognitive Subscale (13 items) [ADAS-Cog 13], and AD Cooperative&#xD;
      Study-Activities of Daily Living Inventory (Mild Cognitive Impairment version)&#xD;
      [ADCS-ADL-MCI].&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was discontinued based on futility analysis done and not based on safety concerns.&#xD;
    Follow-up visits and closing out study activities are completed&#xD;
  </why_stopped>
  <start_date type="Actual">September 15, 2015</start_date>
  <completion_date type="Actual">August 5, 2019</completion_date>
  <primary_completion_date type="Actual">August 5, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) Score at Week 78</measure>
    <time_frame>Baseline, Week 78</time_frame>
    <description>CDR-SB integrates assessments from 3 domains of cognition (memory, orientation, judgment/problem-solving) and 3 domains of function (community affairs, home/hobbies, personal care). Following caregiver interview and systematic patient examination, the rater assigns a score describing the participant's current performance level in each of these domains of life functioning. Prespecified severity anchors range from none = 0, questionable = 0.5, mild = 1, moderate = 2 to severe = 3 (the personal care domain omits the 0.5 score). &quot;Sum of boxes&quot; scoring methodology sums the score for each of the 6 domains and provides a value ranging from 0 to 18 that can change in increments of 0.5 or greater. Higher scores indicate greater disease severity. Mixed model for repeated measures (MMRM) analysis was used to analyze change from baseline in CDR-SB. A positive change from baseline indicates clinical decline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Mini Mental State Examination (MMSE) Score at Week 78</measure>
    <time_frame>Baseline, Week 78</time_frame>
    <description>The MMSE is a widely used performance-based test of global cognitive status. It consists of 11 tasks that assess orientation, word recall, attention and calculation, language abilities, and visuospatial functions. The scores from the 11 tests are combined to obtain the total score, which ranges from 0 to 30, with lower scores over time indicating increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in MMSE. A negative change from baseline indicates clinical decline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale (13 Items) (ADAS-Cog 13) at Week 78</measure>
    <time_frame>Baseline, Week 78</time_frame>
    <description>ADAS-Cog13 comprises both cognitive tasks and clinical ratings of cognitive performance. The scale items capture word recall, ability to follow commands, the ability to correctly copy or draw an image, naming, the ability to interact with everyday objects, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure for delayed word recall and concentration/distractibility. The total score ranges from 0 to 85. An increase in score over time indicates increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in ADAS-Cog 13. A positive change from baseline indicates clinical decline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment Version) (ADCS-ADL-MCI) Score at Week 78</measure>
    <time_frame>Baseline, Week 78</time_frame>
    <description>The ADCS-ADL-MCI consists of 17 instrumental items (e.g., shopping, preparing meals, using household appliances) and 1 basic item (getting dressed). Ratings reflect caregiver observations about the patient's actual functioning over the previous month and provide an assessment of change in the functional state of the participant over time. The total score ranges from 0 to 53, with lower values over time reflecting functional deterioration. MMRM analysis was used to analyze change from baseline in ADAS-ADL-MCI. A negative change from baseline indicates clinical decline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1643</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Low Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Monthly intravenous (IV) infusions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Monthly intravenous (IV) infusions</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aducanumab (BIIB037)</intervention_name>
    <description>Low dose</description>
    <arm_group_label>Low Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aducanumab (BIIB037)</intervention_name>
    <description>High dose</description>
    <arm_group_label>High Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>High Dose</arm_group_label>
    <arm_group_label>Low Dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Must meet all of the following clinical criteria for MCI due to AD or mild AD and must&#xD;
             have:&#xD;
&#xD;
          -  A Clinical Dementia Rating (CDR)-Global Score of 0.5.&#xD;
&#xD;
          -  Objective evidence of cognitive impairment at screening&#xD;
&#xD;
          -  An MMSE score between 24 and 30 (inclusive)&#xD;
&#xD;
          -  Must have a positive amyloid Positron Emission Tomography (PET) scan&#xD;
&#xD;
          -  Must consent to apolipoprotein E (ApoE) genotyping&#xD;
&#xD;
          -  If using drugs to treat symptoms related to AD, doses must be stable for at least 8&#xD;
             weeks prior to screening visit 1&#xD;
&#xD;
          -  Must have a reliable informant or caregiver&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Any medical or neurological condition (other than Alzheimer's Disease) that might be a&#xD;
             contributing cause of the subject's cognitive impairment&#xD;
&#xD;
          -  Have had a stroke or Transient Ischemic Attack (TIA) or unexplained loss of&#xD;
             consciousness in the past 1 year&#xD;
&#xD;
          -  Clinically significant unstable psychiatric illness in past 6 months&#xD;
&#xD;
          -  History of unstable angina, myocardial infarction, advanced chronic heart failure, or&#xD;
             clinically significant conduction abnormalities within 1 year prior to Screening&#xD;
&#xD;
          -  Indication of impaired renal or liver function&#xD;
&#xD;
          -  Have human immunodeficiency virus (HIV) infection&#xD;
&#xD;
          -  Have a significant systematic illness or infection in past 30 days&#xD;
&#xD;
          -  Relevant brain hemorrhage, bleeding disorder and cerebrovascular abnormalities&#xD;
&#xD;
          -  Any contraindications to brain magnetic resonance imaging (MRI) or PET scans&#xD;
&#xD;
          -  Alcohol or substance abuse in past 1 year&#xD;
&#xD;
          -  Taking blood thinners (except for aspirin at a prophylactic dose or less)&#xD;
&#xD;
        NOTE: Other protocol defined Inclusion/Exclusion criteria may apply&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Biogen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner Alzheimer's Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xenoscience Inc.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner Sun Health Research Institute</name>
      <address>
        <city>Sun City</city>
        <state>Arizona</state>
        <zip>85351</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Memory Impairments</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renewal Behavioral Health</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>USC Keck School of Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Excell Research, Inc.</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Neuroscience Medical Group</name>
      <address>
        <city>Oxnard</city>
        <state>California</state>
        <zip>93030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anderson Clinical Research</name>
      <address>
        <city>Redlands</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Research Network</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Syrentis Clinical Research</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Joseph Heritage Healthcare</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IMMUNOe International Research Centers</name>
      <address>
        <city>Thornton</city>
        <state>Colorado</state>
        <zip>80233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associated Neurologists of Southern Connecticut, PC</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <zip>06824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University School Of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Center for Clinical Studies, Inc.</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JEM Research Institute</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bradenton Research Center, Inc.</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research</name>
      <address>
        <city>Brooksville</city>
        <state>Florida</state>
        <zip>34601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quantum Laboratories Inc.</name>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <zip>33064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Infinity Clinical Research, LLC</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renstar Medical Research</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34470</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions, Inc.</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Axiom Clinical Research of Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Cognitive Neurology Clinic &amp; ADRC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research Health and Education Foundation, Inc</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NeuroStudies.net, LLC</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josephson, Wallack, Munshower Neurology, PC</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLean Hospital</name>
      <address>
        <city>Belmont</city>
        <state>Massachusetts</state>
        <zip>02478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Center for Memory</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>05201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hattiesburg Clinic, PA</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Lou Ruvo Center for Brain Health</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ActivMed Practices &amp; Research</name>
      <address>
        <city>Portsmouth</city>
        <state>New Hampshire</state>
        <zip>03801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AdvanceMed Research</name>
      <address>
        <city>Lawrenceville</city>
        <state>New Jersey</state>
        <zip>08648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Empire Neurology, PC</name>
      <address>
        <city>Latham</city>
        <state>New York</state>
        <zip>12110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College-New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Winston-Salem, LLC</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Center for Clinical Research, LLC</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn Memory Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roper St. Francis Healthcare</name>
      <address>
        <city>North Charleston</city>
        <state>South Carolina</state>
        <zip>29406-6076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Senior Adult Specialty Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78757</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital Research Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trial Network</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Sciences Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Research Association, Inc</name>
      <address>
        <city>Bennington</city>
        <state>Vermont</state>
        <zip>05201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Neurological, PLLC</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.Z. Klina</name>
      <address>
        <city>Brasschaat</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Bruxelles</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Neurologique &amp; de Réadaptation Fonctionnelle</name>
      <address>
        <city>Fraiture</city>
        <zip>4557</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Groeninge - Campus Kennedylaan</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Delta</name>
      <address>
        <city>Roeselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research.</name>
      <address>
        <city>Kamloops</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research</name>
      <address>
        <city>West Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>True North Clinical Research - Halifax Inc.</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3S 1M7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>True North Clinical Research Kentville, Inc</name>
      <address>
        <city>Kentville</city>
        <state>Nova Scotia</state>
        <zip>B4N 4K9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JBN Medical Diagnostic Services Inc.</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7M 4Y1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's HC- Parkwood Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6C 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bruyere Continuing Care</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1N 5C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kawartha Regional Memory Clinic</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <zip>K9H 2P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Recherches Neuro-Hippocampe Inc.</name>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <zip>J8T 8J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Recherche Sepmus, Inc.</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <zip>J4V 2J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIEX Recherche Sherbrooke Inc.</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 1Z1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Douglas Hospital Research Centre</name>
      <address>
        <city>Verdun</city>
        <state>Quebec</state>
        <zip>H4H 1R3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terveystalo Kamppi</name>
      <address>
        <city>Helsinki</city>
        <zip>00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Itä-Suomen yliopisto, Aivotutkimusyksikkö</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CRST, Clinical Research Services Turku</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <state>Bouches-du-Rhône</state>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse - Hôpital Purpan</name>
      <address>
        <city>Toulouse cedex 9</city>
        <state>Haute Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Recherche Clinique du Gérontopôle - Cité de la Santé</name>
      <address>
        <city>Toulouse</city>
        <state>Haute Garonne</state>
        <zip>31052</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Gui de Chauliac</name>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rennes - Hopital Pontchaillou</name>
      <address>
        <city>Rennes cedex 09</city>
        <state>Ille Et Vilaine</state>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nantes - Hopital Nord Laënnec</name>
      <address>
        <city>Nantes cedex 1</city>
        <state>Loire Atlantique</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Roger Salengro - CHU Lille</name>
      <address>
        <city>Lille Cedex</city>
        <state>Nord</state>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des Charpennes</name>
      <address>
        <city>Villeurbanne</city>
        <state>Rhone</state>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Fernand Widal</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bezirkskrankenhaus Guenzburg</name>
      <address>
        <city>Gunzburg</city>
        <state>Baden Wuerttemberg</state>
        <zip>89312</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ISPG - Institut fuer Studien zur Psychischen Gesundheit</name>
      <address>
        <city>Mannheim</city>
        <state>Baden Wuerttemberg</state>
        <zip>68165</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nervenfachaerztlichen Gemeinschaftspraxis Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden Wuerttemberg</state>
        <zip>89078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden Wuerttemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Hohe Warte Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <state>Bayern</state>
        <zip>95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut fuer Schlaganfall- und Demenzforschung (ISD)</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der TU Muenchen</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuropraxis Muenchen Sued</name>
      <address>
        <city>Unterhaching</city>
        <state>Bayern</state>
        <zip>82008</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuro Centrum Odenwald</name>
      <address>
        <city>Erbach</city>
        <state>Hessen</state>
        <zip>64711</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Duesseldorf AoeR</name>
      <address>
        <city>Duesseldorf</city>
        <state>Nordrhein Westfalen</state>
        <zip>40629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <state>Nordrhein Westfalen</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum f. Neurologisch- Psychiatrische Studien und Begutachtung</name>
      <address>
        <city>Siegen</city>
        <state>Nordrhein Westfalen</state>
        <zip>57076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis fuer Neurologie, Psychiatrie und Klinische Studien</name>
      <address>
        <city>Bielefeld</city>
        <state>North Rhine-Westphalia</state>
        <zip>33647</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <state>Sachsen</state>
        <zip>09131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kopfzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04275</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Altenburger Land GmbH</name>
      <address>
        <city>Altenburg</city>
        <state>Thueringen</state>
        <zip>04600</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>emovis GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologie im Tempelhofer Hafen</name>
      <address>
        <city>Berlin</city>
        <zip>12099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi</name>
      <address>
        <city>Ponderano</city>
        <state>Biella</state>
        <zip>13875</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Card. G. Panico</name>
      <address>
        <city>Tricase</city>
        <state>Lecce</state>
        <zip>73039</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST di Monza</name>
      <address>
        <city>Monza</city>
        <state>Milano</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Neurologico Carlo Besta</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone</name>
      <address>
        <city>Palermo</city>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia</name>
      <address>
        <city>Perugia</city>
        <zip>06156</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Santa Lucia IRCCS</name>
      <address>
        <city>Roma</city>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Umberto I Pol. di Roma-Università di Roma La Sapienza</name>
      <address>
        <city>Roma</city>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Obu-shi</city>
        <state>Aichi-Ken</state>
        <zip>474-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toon-shi</city>
        <state>Ehime-Ken</state>
        <zip>791-0295</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Fukuoka-shi</city>
        <state>Fukuoka-Ken</state>
        <zip>814-0180</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kurume-shi</city>
        <state>Fukuoka-Ken</state>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Otake-shi</city>
        <state>Hiroshima-Ken</state>
        <zip>739-0696</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Amagasaki-shi</city>
        <state>Hyogo-Ken</state>
        <zip>660-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research site</name>
      <address>
        <city>Himeji-shi</city>
        <state>Hyogo-Ken</state>
        <zip>670-0981</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Himeji-shi</city>
        <state>Hyogo-Ken</state>
        <zip>672-8043</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kobe-shi</city>
        <state>Hyogo-Ken</state>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kita-gun</city>
        <state>Kagawa-Ken</state>
        <zip>761-0793</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto-Fu</state>
        <zip>607-8113</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto-Fu</state>
        <zip>616-8255</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tsu-shi</city>
        <state>Mie-Ken</state>
        <zip>514-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Nishisonogi</city>
        <state>Nagasaki-Ken</state>
        <zip>851-2103</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Yufu-shi</city>
        <state>Oita-Ken</state>
        <zip>879-5593</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kurashiki-shi</city>
        <state>Okayama-Ken</state>
        <zip>710-0813</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Okayama-shi</city>
        <state>Okayama-Ken</state>
        <zip>703-8265</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tsukuba-gun</city>
        <state>Okayama-Ken</state>
        <zip>701-0304</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kishiwada-shi</city>
        <state>Osaka-Fu</state>
        <zip>596-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka-Fu</state>
        <zip>530-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka-Fu</state>
        <zip>545-8586</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka-Fu</state>
        <zip>553-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sennan-shi</city>
        <state>Osaka-Fu</state>
        <zip>590-0503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Suita-shi</city>
        <state>Osaka-Fu</state>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Iwata-shi</city>
        <state>Shizuoka-Ken</state>
        <zip>438-0043</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Shizuoka-shi</city>
        <state>Shizuoka-Ken</state>
        <zip>420-8688</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Shizuoka-shi</city>
        <state>Shizuoka-Ken</state>
        <zip>424-8636</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alzheimer Research Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 GM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medisch Centrum</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Podlaskie Centrum Psychogeriatrii</name>
      <address>
        <city>Bialystok</city>
        <zip>15-732</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PALLMED Sp. z o.o.</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-796</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersyteckie Centrum Kliniczne</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo-Med Zielinski i wspolnicy Sp. j.</name>
      <address>
        <city>Katowice</city>
        <zip>40-650</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPZOZ Centralny Szpital Kliniczny UM w Lodzi</name>
      <address>
        <city>Lodz</city>
        <zip>92-216</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Diagnostyczno - Terapeutyczne &quot;MEDICUS&quot; Sp.z o.o.</name>
      <address>
        <city>Lubin</city>
        <zip>59-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20-950</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologiczny NZOZ Centrum Leczenia SM</name>
      <address>
        <city>Plewiska</city>
        <zip>62-064</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ &quot;NEURO-KARD&quot;, &quot;Ilkowski i Partnerzy&quot; Sp. Partn. Lek.</name>
      <address>
        <city>Poznan</city>
        <zip>61-853</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Medyk</name>
      <address>
        <city>Rzeszow</city>
        <zip>35-055</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuro-Care Gabriela Klodowska</name>
      <address>
        <city>Slaskie</city>
        <zip>41-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ &quot;SENIOR&quot; Poradnia Psychogeriatryczna</name>
      <address>
        <city>Sopot</city>
        <zip>81-855</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osrodek Badan Klinicznych EUROMEDIS</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>mMED Maciej Czarnecki</name>
      <address>
        <city>Warszawa</city>
        <zip>01-697</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>3203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTHAIA Hospital Sant Joan de Deu</name>
      <address>
        <city>Manresa</city>
        <state>Barcelona</state>
        <zip>08243</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofía</name>
      <address>
        <city>Cordoba</city>
        <state>Córdoba</state>
        <zip>14011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Quiron Dexeus</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <zip>8907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skånes Universitetssjukhus, Malmö</name>
      <address>
        <city>Malmö</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus</name>
      <address>
        <city>Mölndal</city>
        <zip>43141</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitetssjukhuset, Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akademiska Sjukhuset</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitären Psychiatrischen Kliniken Basel (UPK)</name>
      <address>
        <city>Basel</city>
        <zip>4025</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinisches Zentrum MZB Biel</name>
      <address>
        <city>Biel/Bienne</city>
        <zip>2502</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genève - HUG</name>
      <address>
        <city>Geneve 14</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civico</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut fuer Regenerative Medizin (IREM) der Universitaet Zuerich, Zentrum fuer Praevention und Demenztherapie</name>
      <address>
        <city>Schlieren</city>
        <zip>8952</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
    <country>United Kingdom</country>
  </removed_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2015</study_first_posted>
  <results_first_submitted>July 1, 2021</results_first_submitted>
  <results_first_submitted_qc>August 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 2, 2021</results_first_posted>
  <disposition_first_submitted>August 4, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>August 4, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">August 5, 2020</disposition_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aducanumab</keyword>
  <keyword>BIIB037</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 28, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/47/NCT02484547/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 11, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/47/NCT02484547/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled at 181 investigative sites in the United States, Belgium, Canada, Finland, France, Germany, Italy, Japan, Netherlands, Poland, Spain, Sweden, and Switzerland from 15 September 2015 to 13 July 2018.</recruitment_details>
      <pre_assignment_details>A total of 1643 participants with Alzhiemer's disease were enrolled and randomized in the study. Of these, 1638 participants received the study drug in placebo-controlled (PC) period. After completing PC period, 771 participants entered and dosed in long-term extension (LTE) period and no participants completed the study due to early termination of the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="P2">
          <title>BIIB037 Low Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="P3">
          <title>BIIB037 High Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="P4">
          <title>BIIB037 Late Start: Low Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to placebo received BIIB037 low dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="P5">
          <title>BIIB037 Late Start: High Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to placebo received BIIB037 high dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="P6">
          <title>BIIB037 Early Start: Low Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to low dose BIIB037 continued to receive the same dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="P7">
          <title>BIIB037 Early Start: High Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to high dose BIIB037 continued to receive the same dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Placebo-Controlled Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="548"/>
                <participants group_id="P2" count="543"/>
                <participants group_id="P3" count="547"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="288"/>
                <participants group_id="P2" count="291"/>
                <participants group_id="P3" count="295"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="260"/>
                <participants group_id="P2" count="252"/>
                <participants group_id="P3" count="252"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Change of Treatment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Consent Withdrawn</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease Progression</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Investigator Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study Visit Burden</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Parent/Guardian</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reason not Specified</title>
              <participants_list>
                <participants group_id="P1" count="216"/>
                <participants group_id="P2" count="194"/>
                <participants group_id="P3" count="183"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Long-Term Extension Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="131">11 PC completers did not enter LTE.</participants>
                <participants group_id="P5" count="132">14 PC completers did not enter LTE.</participants>
                <participants group_id="P6" count="251">40 PC completers did not enter LTE.</participants>
                <participants group_id="P7" count="257">38 PC completers did not enter LTE.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="131"/>
                <participants group_id="P5" count="132"/>
                <participants group_id="P6" count="251"/>
                <participants group_id="P7" count="257"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease Progression</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="4"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Loss of Capacity</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Change of Treatment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Consent Withdrawn</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="7"/>
                <participants group_id="P6" count="13"/>
                <participants group_id="P7" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Investigator Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relocation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study Visit Burden</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Parent/Guardian</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reason not Specified</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="119"/>
                <participants group_id="P5" count="117"/>
                <participants group_id="P6" count="223"/>
                <participants group_id="P7" count="231"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intent-to-Treat (ITT) population was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo).</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="B2">
          <title>BIIB037 Low Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="B3">
          <title>BIIB037 High Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="548"/>
            <count group_id="B2" value="543"/>
            <count group_id="B3" value="547"/>
            <count group_id="B4" value="1638"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.8" spread="7.40"/>
                    <measurement group_id="B2" value="70.6" spread="7.45"/>
                    <measurement group_id="B3" value="70.6" spread="7.47"/>
                    <measurement group_id="B4" value="70.7" spread="7.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="290"/>
                    <measurement group_id="B2" value="269"/>
                    <measurement group_id="B3" value="284"/>
                    <measurement group_id="B4" value="843"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="258"/>
                    <measurement group_id="B2" value="274"/>
                    <measurement group_id="B3" value="263"/>
                    <measurement group_id="B4" value="795"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="128"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="431"/>
                    <measurement group_id="B2" value="432"/>
                    <measurement group_id="B3" value="422"/>
                    <measurement group_id="B4" value="1285"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Reported Due to Confidentiality Regulations</title>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="75"/>
                    <measurement group_id="B4" value="207"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethinicity</title>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="470"/>
                    <measurement group_id="B2" value="470"/>
                    <measurement group_id="B3" value="461"/>
                    <measurement group_id="B4" value="1401"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Reported Due to Confidentiality Regulations</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="169"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) Score at Week 78</title>
        <description>CDR-SB integrates assessments from 3 domains of cognition (memory, orientation, judgment/problem-solving) and 3 domains of function (community affairs, home/hobbies, personal care). Following caregiver interview and systematic patient examination, the rater assigns a score describing the participant's current performance level in each of these domains of life functioning. Prespecified severity anchors range from none = 0, questionable = 0.5, mild = 1, moderate = 2 to severe = 3 (the personal care domain omits the 0.5 score). &quot;Sum of boxes&quot; scoring methodology sums the score for each of the 6 domains and provides a value ranging from 0 to 18 that can change in increments of 0.5 or greater. Higher scores indicate greater disease severity. Mixed model for repeated measures (MMRM) analysis was used to analyze change from baseline in CDR-SB. A positive change from baseline indicates clinical decline.</description>
        <time_frame>Baseline, Week 78</time_frame>
        <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O2">
            <title>BIIB037 Low Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O3">
            <title>BIIB037 High Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) Score at Week 78</title>
          <description>CDR-SB integrates assessments from 3 domains of cognition (memory, orientation, judgment/problem-solving) and 3 domains of function (community affairs, home/hobbies, personal care). Following caregiver interview and systematic patient examination, the rater assigns a score describing the participant's current performance level in each of these domains of life functioning. Prespecified severity anchors range from none = 0, questionable = 0.5, mild = 1, moderate = 2 to severe = 3 (the personal care domain omits the 0.5 score). &quot;Sum of boxes&quot; scoring methodology sums the score for each of the 6 domains and provides a value ranging from 0 to 18 that can change in increments of 0.5 or greater. Higher scores indicate greater disease severity. Mixed model for repeated measures (MMRM) analysis was used to analyze change from baseline in CDR-SB. A positive change from baseline indicates clinical decline.</description>
          <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="288"/>
                <count group_id="O2" value="290"/>
                <count group_id="O3" value="299"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.74" spread="0.115"/>
                    <measurement group_id="O2" value="1.47" spread="0.116"/>
                    <measurement group_id="O3" value="1.35" spread="0.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low Dose, BIIB037 High Dose), difference with Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in CDR-SB as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline CDR-SB, baseline CDR-SB by visit interaction, baseline MMSE, AD symptomatic medication use at baseline, region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0901</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>-0.26</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.569</ci_lower_limit>
            <ci_upper_limit>0.041</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low Dose, BIIB037 High Dose), difference with Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in CDR-SB as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline CDR-SB, baseline CDR-SB by visit.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0120</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>-0.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.694</ci_lower_limit>
            <ci_upper_limit>-0.086</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Mini Mental State Examination (MMSE) Score at Week 78</title>
        <description>The MMSE is a widely used performance-based test of global cognitive status. It consists of 11 tasks that assess orientation, word recall, attention and calculation, language abilities, and visuospatial functions. The scores from the 11 tests are combined to obtain the total score, which ranges from 0 to 30, with lower scores over time indicating increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in MMSE. A negative change from baseline indicates clinical decline.</description>
        <time_frame>Baseline, Week 78</time_frame>
        <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O2">
            <title>BIIB037 Low Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O3">
            <title>BIIB037 High Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Mini Mental State Examination (MMSE) Score at Week 78</title>
          <description>The MMSE is a widely used performance-based test of global cognitive status. It consists of 11 tasks that assess orientation, word recall, attention and calculation, language abilities, and visuospatial functions. The scores from the 11 tests are combined to obtain the total score, which ranges from 0 to 30, with lower scores over time indicating increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in MMSE. A negative change from baseline indicates clinical decline.</description>
          <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="288"/>
                <count group_id="O2" value="293"/>
                <count group_id="O3" value="299"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.3" spread="0.22"/>
                    <measurement group_id="O2" value="-3.3" spread="0.22"/>
                    <measurement group_id="O3" value="-2.7" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low Dose, BIIB037 High Dose), difference from Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in MMSE as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline MMSE, baseline MMSE by visit interaction, AD symptomatic medication use at baseline, region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7578</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>-0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.65</ci_lower_limit>
            <ci_upper_limit>0.48</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low Dose, BIIB037 High Dose), difference from Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in MMSE as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline MMSE, baseline MMSE by visit interaction, AD symptomatic medication use at baseline, region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0493</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale (13 Items) (ADAS-Cog 13) at Week 78</title>
        <description>ADAS-Cog13 comprises both cognitive tasks and clinical ratings of cognitive performance. The scale items capture word recall, ability to follow commands, the ability to correctly copy or draw an image, naming, the ability to interact with everyday objects, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure for delayed word recall and concentration/distractibility. The total score ranges from 0 to 85. An increase in score over time indicates increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in ADAS-Cog 13. A positive change from baseline indicates clinical decline.</description>
        <time_frame>Baseline, Week 78</time_frame>
        <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O2">
            <title>BIIB037 Low Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O3">
            <title>BIIB037 High Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale (13 Items) (ADAS-Cog 13) at Week 78</title>
          <description>ADAS-Cog13 comprises both cognitive tasks and clinical ratings of cognitive performance. The scale items capture word recall, ability to follow commands, the ability to correctly copy or draw an image, naming, the ability to interact with everyday objects, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure for delayed word recall and concentration/distractibility. The total score ranges from 0 to 85. An increase in score over time indicates increasing cognitive impairment. MMRM analysis was used to analyze change from baseline in ADAS-Cog 13. A positive change from baseline indicates clinical decline.</description>
          <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="287"/>
                <count group_id="O2" value="289"/>
                <count group_id="O3" value="293"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.162" spread="0.4049"/>
                    <measurement group_id="O2" value="4.461" spread="0.4074"/>
                    <measurement group_id="O3" value="3.763" spread="0.4036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group(Placebo,BIIB037 Low Dose,BIIB037 High Dose),difference from Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in ADASCog 13 as dependent variable and with fixed effects of treatment group,categorical visit,treatment-by-visit interaction,baseline ADAS-Cog 13,baseline ADAS-Cog 13 by visit interaction,baseline MMSE,AD symptomatic medication use at baseline,region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1962</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>-0.701</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.7649</ci_lower_limit>
            <ci_upper_limit>0.3627</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group(Placebo,BIIB037 Low Dose,BIIB037 High Dose),difference from Placebo, 95% confidence interval and p-value at each time point were based on an MMRM model, with change from baseline in ADASCog 13 as dependent variable and with fixed effects of treatment group,categorical visit,treatment-by-visit interaction,baseline ADAS-Cog 13,baseline ADAS-Cog 13 by visit interaction,baseline MMSE,AD symptomatic medication use at baseline,region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0097</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>-1.400</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.4596</ci_lower_limit>
            <ci_upper_limit>-0.3396</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment Version) (ADCS-ADL-MCI) Score at Week 78</title>
        <description>The ADCS-ADL-MCI consists of 17 instrumental items (e.g., shopping, preparing meals, using household appliances) and 1 basic item (getting dressed). Ratings reflect caregiver observations about the patient's actual functioning over the previous month and provide an assessment of change in the functional state of the participant over time. The total score ranges from 0 to 53, with lower values over time reflecting functional deterioration. MMRM analysis was used to analyze change from baseline in ADAS-ADL-MCI. A negative change from baseline indicates clinical decline.</description>
        <time_frame>Baseline, Week 78</time_frame>
        <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O2">
            <title>BIIB037 Low Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
          <group group_id="O3">
            <title>BIIB037 High Dose (PC Period)</title>
            <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment Version) (ADCS-ADL-MCI) Score at Week 78</title>
          <description>The ADCS-ADL-MCI consists of 17 instrumental items (e.g., shopping, preparing meals, using household appliances) and 1 basic item (getting dressed). Ratings reflect caregiver observations about the patient's actual functioning over the previous month and provide an assessment of change in the functional state of the participant over time. The total score ranges from 0 to 53, with lower values over time reflecting functional deterioration. MMRM analysis was used to analyze change from baseline in ADAS-ADL-MCI. A negative change from baseline indicates clinical decline.</description>
          <population>ITT was defined as all randomized participants who had received at least one dose of study treatment (Aducanumab or Placebo). 'Number of Participants Analyzed' signifies number of participants analyzed in this outcome measure.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="283"/>
                <count group_id="O2" value="286"/>
                <count group_id="O3" value="295"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="0.38"/>
                    <measurement group_id="O2" value="-3.5" spread="0.38"/>
                    <measurement group_id="O3" value="-2.5" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low dose and BIIB037 High Dose), difference from Placebo,95% CI and p-value at each time point were based on an MMRM model, with change from baseline in ADCSADL-MCI as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline ADCS-ADL-MCI, baseline ADCS-ADL-MCI by visit interaction, baseline MMSE, AD symptomatic medication use at baseline, region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1515</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>0.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.27</ci_lower_limit>
            <ci_upper_limit>1.73</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Adjusted mean for each treatment group (Placebo, BIIB037 Low dose and BIIB037 High Dose), difference from Placebo,95% CI and p-value at each time point were based on an MMRM model, with change from baseline in ADCSADL-MCI as dependent variable and with fixed effects of treatment group, categorical visit, treatment-by-visit interaction, baseline ADCS-ADL-MCI, baseline ADCS-ADL-MCI by visit interaction, baseline MMSE, AD symptomatic medication use at baseline, region, and laboratory ApoE status.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0006</p_value>
            <method>MMRM</method>
            <param_type>Difference</param_type>
            <param_value>1.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>2.74</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From First Dose to End of Study (up to 4 years)</time_frame>
      <desc>The safety population was defined as all randomised participants who had received at least one dose of study treatment. In PC period, 1 participant randomized to placebo, inadvertently received 1 or more doses of active treatment (Low Dose) during the PC period. For participants affected, a participant was counted only once within each system organ class/preferred term/study period.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037-matching placebo intravenously (IV) in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="E2">
          <title>BIIB037 Low Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 low dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="E3">
          <title>BIIB037 High Dose (PC Period)</title>
          <description>Participants received a maximum of 20 infusions of BIIB037 high dose IV in PC period, administered approximately once every 4 weeks for up to approximately 1.5 years.</description>
        </group>
        <group group_id="E4">
          <title>BIIB037 Late Start: Low Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to placebo received BIIB037 low dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="E5">
          <title>BIIB037 Late Start: High Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to placebo received BIIB037 high dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="E6">
          <title>BIIB037 Early Start: Low Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to low dose BIIB037 continued to receive the same dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
        <group group_id="E7">
          <title>BIIB037 Early Start: High Dose (LTE Period)</title>
          <description>Following PC period, participants randomized to high dose BIIB037 continued to receive the same dose, IV infusion, approximately every 4 weeks for up to 2 years in LTE period.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="81" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="73" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="25" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="25" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness bilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Age-related macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Acquired oesophageal web</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Femoral hernia strangulated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Obstructive pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Medical device site joint pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cystitis klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Human anaplasmosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lymphangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumonia respiratory syncytial viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Animal attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Animal scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cardiac contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Epiphyseal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastrointestinal procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Diffuse large b-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Invasive lobular breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage iv</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Medullary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>T-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Thymoma malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Amyloid related imaging abnormality-oedema/effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Dementia alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Focal dyscognitive seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Guillain-barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Intracranial venous sinus thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Quadriparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Sensorimotor disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Superficial siderosis of central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Thrombotic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Behaviour disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Mania</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Neuropsychiatric symptoms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Somatic symptom disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urethral disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Adnexa uteri cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Spermatic cord cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Laryngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Lung perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hypertensive urgency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="353" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="385" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="428" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="55" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="56" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="87" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="107" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="42" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="89" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="73" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="32" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="42" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="86" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="106" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="21" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Amyloid related imaging abnormality-oedema/effusion</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="138" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="183" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="31" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="22" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="55" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="84" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="109" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="107" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="20" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Superficial siderosis of central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="544"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="547"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="131"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="132"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="251"/>
                <counts group_id="E7" subjects_affected="14" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information.PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was halted prematurely based on a prespecified futility analysis and not based on safety concerns. Participants discontinued due to study termination are included in &quot;Reason not Specified&quot; category in participant flow tables above.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Biogen Study Medical Director</name_or_title>
      <organization>Biogen</organization>
      <phone>866-633-4636</phone>
      <email>clinicaltrials@biogen.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

